  Background. Alzheimer's disease and related dementia (ADRD) are characterized
by multiple and progressive anatomo clinical changes. Yet, modeling changes
over disease course from cohort data is challenging as the usual timescales are
inappropriate and time-to-clinical diagnosis is available on small subsamples
of participants with short follow-up durations prior to diagnosis. One solution
to circumvent this challenge is to define the disease time as a latent
variable.
  Methods: We developed a multivariate mixed model approach that realigns
individual trajectories into the latent disease time to describe disease
progression. Our methodology exploits the clinical diagnosis information as a
partially observed and approximate reference to guide the estimation of the
latent disease time. The model estimation was carried out in the Bayesian
Framework using Stan. We applied the methodology to 2186 participants of the
MEMENTO study with 5-year follow-up. Repeated measures of 12 ADRD markers
stemmed from cerebrospinal fluid (CSF), brain imaging and cognitive tests were
analyzed.
  Result: The estimated latent disease time spanned over twenty years before
the clinical diagnosis. Considering the profile of a woman aged 70 with a high
level of education and APOE4 carrier (the main genetic risk factor for ADRD),
CSF markers of tau proteins accumulation preceded markers of brain atrophy by 5
years and cognitive decline by 10 years. We observed that individual
characteristics could substantially modify the sequence and timing of these
changes.
  Conclusion: Our disease progression model does not only realign trajectories
into the most homogeneous way. It accounts for the inherent residual
inter-individual variability in dementia progression to describe the long-term
changes according to the years preceding clinical diagnosis, and to provide
clinically meaningful information on the sequence of events.
